Effect of 5-diazouracil on the synthetic and catabolic utilization of thymine in rat liver.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001391:Azo Compounds / Q000494:pharmacology; D002247:Carbon Isotopes; D003513:Cycloheximide / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis*; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D008099:Liver / Q000378:metabolism*; D010088:Oxidoreductases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000378:metabolism; D051381:Rats; D013268:Stimulation, Chemical; D013941:Thymine / Q000378:metabolism*; D014498:Uracil / Q000494:pharmacology* / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D001391:Azo Compounds; D002247:Carbon Isotopes; D011743:Pyrimidines; C004758:5-diazouracil; D003609:Dactinomycin; D014498:Uracil; D004247:DNA; D003513:Cycloheximide; D010088:Oxidoreductases; D013941:Thymine